Osteoporosis risk screening for women in a community pharmacy

被引:14
|
作者
Liu, Yifei [1 ]
Nevins, Justin C. [2 ]
Carruthers, Kara M. [3 ]
Doucette, William R. [1 ]
McDonough, Randal P. [4 ]
Pan, Xiaoyun [1 ]
机构
[1] Univ Iowa, Coll Pharm, Program Pharmaceut Socioecon, Iowa City, IA 52242 USA
[2] Univ Iowa, Inpatient Care Units, Iowa City, IA 52242 USA
[3] Main Locust Pharm Clin & Med Supply, Clin Serv, Iowa City, IA USA
[4] Towncrest Pharm, Iowa City, IA USA
关键词
osteoporosis; bone mineral density screening; community and ambulatory pharmacy; cost analysis; business models; pharmacy services;
D O I
10.1331/JAPhA.2007.05107
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To describe the development, implementation, and financial aspects of a sustainable osteoporosis screening service in a community pharmacy and report osteoporosis risk factors for women screened during the 48 months in which the screening service was in operation. Setting: An independent community pharmacy (Main at Locust Pharmacy Clinic) in Davenport, Iowa, beginning in 1999. Practice description: The osteoporosis screening service was provided by a staff pharmacist, a pharmacy resident, or a combination of a pharmacist and a resident. The service included use of the Hologic Sahara Bone Sonometer at the heel and education of the patient. Patient education consisted of a discussion of screening results, an overview of osteoporosis, and recommendations to address risk factors. Practice innovation: For patients who received osteoporosis screening, an overall cumulative risk score and a cumulative modifiable risk score were calculated. Patients were identified as having high (T-score <=-1), moderate (-1 < T-score < 0), or low (T-score >= 0) risk. An analysis was performed to determine the net financial gain or loss of osteoporosis screening. Intervention: Osteoporosis screening service. Main outcome measures: T-score, overall cumulative risk score, cumulative modifiable risk score, and net financial gain of service. Results: A total of 444 women received the osteoporosis screening service during 48 months. More than 90% of the women had an overall cumulative risk score of at least 3, and 83.3% had at least one modifiable risk factor. According to the bone density tests, about 58% of the women were at high risk for osteoporosis and 25.7% were at moderate risk. The service had a net gain if provided by a pharmacist ($4,823.72), a resident ($8,153.72), or a combination of a pharmacist and a resident ($6,488.72). Conclusion: This pharmacy-based osteoporosis screening service effectively identified patients at risk for osteoporosis and was sustainable for 48 months. Other community pharmacies are encouraged to offer similar services.
引用
收藏
页码:521 / U121
页数:13
相关论文
共 50 条
  • [21] Screening for osteoporosis in postmenopausal women
    Fink, K
    Clark, B
    [J]. AMERICAN FAMILY PHYSICIAN, 2004, 69 (01) : 139 - 140
  • [22] OUTCOME OF CHOLESTEROL SCREENING IN A COMMUNITY PHARMACY
    IBRAHIM, OM
    CATANIA, PN
    MERGENER, MA
    SUPERNAW, RB
    [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (09): : 817 - 821
  • [23] Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
    Carolyn J. Crandall
    [J]. Current Osteoporosis Reports, 2015, 13 : 287 - 301
  • [25] Osteoporosis screening in a population of perimenopausal working women: Risk fracture evaluation
    Galmarini, V.
    Gandolini, G.
    Bevilacqua, M.
    Santi, I.
    Massarotti, M.
    Pietrogrande, L.
    Longhi, M.
    Rondena, M.
    [J]. BONE, 2011, 48 : S202 - S202
  • [26] Screening for osteoporosis risk by clinical factors in women following physiologic menopause
    Diez, A
    Puig, J
    Nogues, X
    Knobel, H
    Minguez, S
    Supervia, A
    Mellibovsky, L
    Arnau, MD
    Carreras, R
    Serrano, S
    Aubia, J
    [J]. MEDICINA CLINICA, 1998, 110 (04): : 121 - 124
  • [27] Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
    Crandall, Carolyn J.
    [J]. CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (05) : 287 - 301
  • [28] The evaluation of type 2 diabetes mellitus risk screening at community pharmacy setting
    Aygun, L.
    Sari, H.
    Okuyan, B.
    Sancar, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 226 - 226
  • [29] The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting
    Willis, Andrew
    Rivers, Peter
    Gray, Laura J.
    Davies, Melanie
    Khunti, Kamlesh
    [J]. PLOS ONE, 2014, 9 (04):
  • [30] Dietary calcium intake and osteoporosis screening through women in a semiurban Greek community
    Bakides, S.
    Gkiotsaliti, S.
    Zannou, A.
    Kotis, M.
    Dimaresi, T.
    Papouli, F.
    Soumpasis, C.
    [J]. BONE, 2012, 50 : S151 - S152